Correlation Between Gilead Sciences and Novartis
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Novartis AG, you can compare the effects of market volatilities on Gilead Sciences and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Novartis.
Diversification Opportunities for Gilead Sciences and Novartis
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Gilead and Novartis is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Novartis AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Novartis go up and down completely randomly.
Pair Corralation between Gilead Sciences and Novartis
Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.71 times more return on investment than Novartis. However, Gilead Sciences is 1.42 times less risky than Novartis. It trades about 0.12 of its potential returns per unit of risk. Novartis AG is currently generating about -0.09 per unit of risk. If you would invest 8,808 in Gilead Sciences on August 30, 2024 and sell it today you would earn a total of 433.00 from holding Gilead Sciences or generate 4.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Novartis AG
Performance |
| Timeline |
| Gilead Sciences |
| Novartis AG |
Gilead Sciences and Novartis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Novartis
The main advantage of trading using opposite Gilead Sciences and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.| Gilead Sciences vs. Ikena Oncology | Gilead Sciences vs. Eliem Therapeutics | Gilead Sciences vs. HCW Biologics | Gilead Sciences vs. RenovoRx |
| Novartis vs. Roche Holding AG | Novartis vs. AstraZeneca PLC | Novartis vs. Roche Holding Ltd | Novartis vs. Sanofi ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |